These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 36455619)

  • 1. Laboratory Testing for Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: A Narrative Review.
    Warkentin TE; Greinacher A
    Semin Thromb Hemost; 2023 Sep; 49(6):621-633. PubMed ID: 36455619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of anti-PF4 versus anti-PF4/heparin reactivity using fluid-phase enzyme immunoassay for 4 anti-PF4 disorders: classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, vaccine-induced immune thrombotic thrombocytopenia, and spontaneous HIT.
    Warkentin TE; Arnold DM; Sheppard JI; Moore JC; Kelton JG; Nazy I
    J Thromb Haemost; 2023 Aug; 21(8):2268-2276. PubMed ID: 37182698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic anti-PF4 immune disorders: HIT, VITT, and beyond.
    Greinacher A; Warkentin TE
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):1-10. PubMed ID: 38066843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory testing for VITT antibodies.
    Warkentin TE; Greinacher A
    Semin Hematol; 2022 Apr; 59(2):80-88. PubMed ID: 35512905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative interpretation of PF4/heparin-EIA optical densities in predicting platelet-activating VITT antibodies.
    Schönborn L; Thiele T; Esefeld M; El Debuch K; Wesche J; Seck SE; Kaderali L; Wolff M; Warkentin TE; Greinacher A
    J Thromb Haemost; 2022 Nov; 20(11):2579-2586. PubMed ID: 36006172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of 1E12, a monoclonal anti-platelet factor 4 antibody, to improve the diagnosis of vaccine-induced immune thrombotic thrombocytopenia.
    Vayne C; Rollin J; Clare R; Daka M; Atsouawe M; Guéry EA; Cauchie P; Cordonnier C; Cuisenier P; De Maistre E; Donnard M; Drillaud N; Faille D; Galinat H; Gouin-Thibault I; Lemoine S; Mourey G; Mullier F; Siguret V; Susen S; Godon A; Nazy I; Gruel Y; Pouplard C
    J Thromb Haemost; 2024 Aug; 22(8):2306-2315. PubMed ID: 38762021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique features of vaccine-induced immune thrombotic thrombocytopenia; a new anti-platelet factor 4 antibody-mediated disorder.
    Venier LM; Clerici B; Bissola AL; Modi D; Jevtic SD; Radford M; Mahamad S; Nazy I; Arnold DM
    Int J Hematol; 2023 Mar; 117(3):341-348. PubMed ID: 36574172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heparin-induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia: novel insights on anti-platelet factor 4 antibodies].
    Atsushi Y
    Rinsho Ketsueki; 2022; 63(9):1233-1241. PubMed ID: 36198549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating anti-PF4 disorders: An overview.
    Warkentin TE
    Semin Hematol; 2022 Apr; 59(2):59-71. PubMed ID: 35512902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Novel disease entities due to antiplatelet factor 4 antibodies: HIT, aHIT, and VITT].
    Yasumoto A
    Rinsho Ketsueki; 2022; 63(5):454-462. PubMed ID: 35662171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure.
    Schönborn L; Esteban O; Wesche J; Dobosz P; Broto M; Puig SR; Fuhrmann J; Torres R; Serra J; Llevadot R; Palicio M; Wang JJ; Gordon TP; Lindhoff-Last E; Hoffmann T; Alberio L; Langer F; Boehme C; Biguzzi E; Grosse L; Endres M; Liman T; Thiele T; Warkentin TE; Greinacher A
    Blood; 2023 Dec; 142(26):2305-2314. PubMed ID: 37883798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory approach for vaccine-induced thrombotic thrombocytopenia diagnosis in the Netherlands.
    Meier RT; Porcelijn L; Hofstede-van Egmond S; Henskens YMC; Coutinho JM; Kruip MJHA; Stroobants AK; Zwaginga JJ; van der Bom JG; van der Schoot CE; de Haas M; Kapur R
    Vox Sang; 2024 Jul; 119(7):728-736. PubMed ID: 38597072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory testing for platelet factor 4 antibodies: differential utility for diagnosis/exclusion of heparin induced thrombocytopenia versus suspected vaccine induced thrombotic thrombocytopenia.
    Favaloro EJ; Pasalic L; Henry B; Lippi G
    Pathology; 2022 Apr; 54(3):254-261. PubMed ID: 35125202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-PF4 testing for vaccine-induced immune thrombocytopenia and thrombosis (VITT): Results from a NEQAS, ECAT and SSC collaborative exercise in 385 centers worldwide.
    Reilly-Stitt C; Jennings I; Kitchen S; Makris M; Meijer P; de Maat M; Scully M; Bakchoul T; Walker ID
    J Thromb Haemost; 2022 Aug; 20(8):1875-1879. PubMed ID: 35603519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-the-shelf cryopreserved platelets for the detection of HIT and VITT antibodies.
    Kanack AJ; Jones CG; Singh B; Leger RR; Splinter NP; Heikal NM; Pruthi RK; Chen D; George G; Abou-Ismail MY; Wool GD; Gundabolu K; Padmanabhan A
    Blood; 2022 Dec; 140(25):2722-2729. PubMed ID: 35998675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies against platelet factor 4 and the risk of cerebral venous sinus thrombosis in patients with vaccine-induced immune thrombotic thrombocytopenia.
    Huynh A; Arnold DM; Ivetic N; Clare R; Hadzi-Tosev M; Liu Y; Smith JW; Bissola AL; Daka M; Kelton JG; Nazy I
    J Thromb Haemost; 2023 Oct; 21(10):2833-2843. PubMed ID: 37394121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet factor 4 triggers thrombo-inflammation by bridging innate and adaptive immunity.
    Greinacher A; Warkentin TE
    Int J Lab Hematol; 2023 Jun; 45 Suppl 2():11-22. PubMed ID: 37150909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-Induced Thrombotic Thrombocytopenia (HITT) and Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): Similar but Different.
    Favaloro EJ; Pasalic L
    Methods Mol Biol; 2023; 2663():405-415. PubMed ID: 37204726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Uncommon thrombotic complications after SARS-CoV-2 vaccination].
    Musil D
    Vnitr Lek; 2021; 67(5):297-302. PubMed ID: 35459396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia.
    Huynh A; Kelton JG; Arnold DM; Daka M; Nazy I
    Nature; 2021 Aug; 596(7873):565-569. PubMed ID: 34233346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.